A Stable Irinotecan Liposome with Enhanced Antitumor Activity in a Range of Tumor Models
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Stable Irinotecan Liposome with Enhanced Antitumor Activity in a Range of Tumor Models
Authors
Keywords
-
Journal
PHARMACEUTICAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-01
DOI
10.1007/s11095-023-03622-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liposomal Formulations in Clinical Use: An Updated Review
- (2017) Upendra Bulbake et al. Pharmaceutics
- N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy
- (2016) Jennifer A. Crozier et al. Clinical Breast Cancer
- Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002)
- (2016) A. Tsuburaya et al. CLINICAL ONCOLOGY
- Cryo-electron microscopy and cryo-electron tomography of nanoparticles
- (2016) Phoebe L. Stewart Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- New Developments in Liposomal Drug Delivery
- (2015) Bhushan S. Pattni et al. CHEMICAL REVIEWS
- Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503)
- (2015) Koji Matsumoto et al. GYNECOLOGIC ONCOLOGY
- Uptake and transfection efficiency of PEGylated cationic liposome–DNA complexes with and without RGD-tagging
- (2014) Ramsey N. Majzoub et al. BIOMATERIALS
- Active loading liposomal irinotecan hydrochloride: Preparation, in vitro and in vivo evaluation
- (2013) Hongyan Wei et al. Asian Journal of Pharmaceutical Sciences
- Comparative studies of irinotecan-loaded polyethylene glycol-modified liposomes prepared using different PEG-modification methods
- (2012) Keisuke Yoshino et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer
- (2012) David R. Spigel et al. LUNG CANCER
- Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside
- (2011) Feng Yang et al. CANCER TREATMENT REVIEWS
- Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancer
- (2011) Yasunori Murata et al. EUROPEAN JOURNAL OF CANCER
- Unusual Low Proton Permeability of Liposomes Prepared from the Endogenous Myelin Lipids
- (2010) Ricardo S. Díaz et al. JOURNAL OF NEUROCHEMISTRY
- Randomized Phase II Trial of Irinotecan with Paclitaxel or Gemcitabine for Non-small Cell Lung Cancer: Association of UGT1A1*6 and UGT1A1*27 with Severe Neutropenia
- (2010) Yoichi Nakamura et al. Journal of Thoracic Oncology
- Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors
- (2009) Yoshiyuki Hattori et al. JOURNAL OF CONTROLLED RELEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation